Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39053
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhu, C.-
dc.contributor.authorKalincik, T.-
dc.contributor.authorHorakova, D.-
dc.contributor.authorZhen, Z.-
dc.contributor.authorBuzzard, K.-
dc.contributor.authorSkibina, O.-
dc.contributor.authorAlroughani, R.-
dc.contributor.authorIzquierdo, G.-
dc.contributor.authorEichau, S.-
dc.contributor.authorKuhle, J.-
dc.contributor.authorPatti, F.-
dc.contributor.authorGrand'Maison, F.-
dc.contributor.authorHodgkinson, S.-
dc.contributor.authorGrammond, P.-
dc.contributor.authorLechner-Scott, J.-
dc.contributor.authorButler, E.-
dc.contributor.authorPrat, A.-
dc.contributor.authorGirard, M.-
dc.contributor.authorDuquette, P.-
dc.contributor.authorMacdonell, R.-
dc.contributor.authorWeinstock-Guttman, B.-
dc.contributor.authorOzakbas, S.-
dc.contributor.authorSlee, M.-
dc.contributor.authorSa, M. Jose-
dc.contributor.authorVan Pesch, V.-
dc.contributor.authorBarnett, M.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorGerlach, O.-
dc.contributor.authorPrevost, J.-
dc.contributor.authorTerzi, M.-
dc.contributor.authorBoz, C.-
dc.contributor.authorLaureys, G.-
dc.contributor.authorVan Hijfte, L.-
dc.contributor.authorKermode, A.-
dc.contributor.authorGarber, J.-
dc.contributor.authorYamout, B.-
dc.contributor.authorKhoury, S. J.-
dc.contributor.authorJokubaitis, V.-
dc.contributor.authorMonif, M.-
dc.contributor.authorMerlo, D.-
dc.contributor.authorVan der Walt, A.-
dc.contributor.authorButzkueven, H.-
dc.date.accessioned2022-12-15T11:28:45Z-
dc.date.available2022-12-15T11:28:45Z-
dc.date.issued2022-
dc.date.submitted2022-12-09T13:39:39Z-
dc.identifier.citationMultiple Sclerosis Journal, 28 (S3) , p. 645 -647-
dc.identifier.urihttp://hdl.handle.net/1942/39053-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleEfficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 26-28, 2022-
local.bibliographicCitation.conferencename38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.epage647-
dc.identifier.issueS3-
dc.identifier.spage645-
dc.identifier.volume28-
local.format.pages3-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000866540802331-
local.provider.typewosris-
local.description.affiliation[Zhu, C.; Buzzard, K.; Skibina, O.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A.; Butzkueven, H.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.-
local.description.affiliation[Kalincik, T.] Univ Melbourne, Dept Neurosci, Melbourne, Vic, Australia.-
local.description.affiliation[Horakova, D.] Charles Univ Prague, Prague, Czech Republic.-
local.description.affiliation[Horakova, D.] Gen Univ Hosp, Prague, Czech Republic.-
local.description.affiliation[Zhen, Z.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.-
local.description.affiliation[Alroughani, R.] Amiri Hosp, Sharq, Kuwait.-
local.description.affiliation[Izquierdo, G.; Eichau, S.] Hosp Univ Virgen Macarena, Seville, Spain.-
local.description.affiliation[Kuhle, J.] Univ Hosp, Basel, Switzerland.-
local.description.affiliation[Kuhle, J.] Univ Basel, Basel, Switzerland.-
local.description.affiliation[Patti, F.] Univ Catania, Catania, Italy.-
local.description.affiliation[Grand'Maison, F.] Neuro Rive Sud, Longueuil, PQ, Canada.-
local.description.affiliation[Hodgkinson, S.] Liverpool Hosp, Sydney, NSW, Australia.-
local.description.affiliation[Grammond, P.] CISSS Chaudiere Appalache, Levis, PQ, Canada.-
local.description.affiliation[Lechner-Scott, J.] Univ Newcastle, Newcastle, NSW, Australia.-
local.description.affiliation[Butler, E.] Monash Med Ctr, Melbourne, Australia.-
local.description.affiliation[Prat, A.; Girard, M.; Duquette, P.] CHUM MS Ctr, Montreal, PQ, Canada.-
local.description.affiliation[Prat, A.; Girard, M.; Duquette, P.] Univ Montreal, Montreal, PQ, Canada.-
local.description.affiliation[Macdonell, R.] Austin Hlth, Melbourne, Australia.-
local.description.affiliation[Weinstock-Guttman, B.] Buffalo Gen Med Ctr, Buffalo, NY USA.-
local.description.affiliation[Ozakbas, S.] Dokuz Eylul Univ, Konak, Turkey.-
local.description.affiliation[Slee, M.] Flinders Univ S Australia, Adelaide, SA, Australia.-
local.description.affiliation[Sa, M. Jose] Ctr Hosp Univ Sao Joao, Porto, Portugal.-
local.description.affiliation[Van Pesch, V.] Clin Univ St Luc, Brussels, Belgium.-
local.description.affiliation[Barnett, M.] Brain & Mind Ctr, Sydney, NSW, Australia.-
local.description.affiliation[Van Wijmeersch, B.] Rehabil & MS Ctr Overpelt, Hasselt, Belgium.-
local.description.affiliation[Van Wijmeersch, B.] Hasselt Univ, Hasselt, Belgium.-
local.description.affiliation[Gerlach, O.] Zuyderland Med Ctr, Sittard Geleen, Netherlands.-
local.description.affiliation[Prevost, J.] CSSS St Jerome, St Jerome, PQ, Canada.-
local.description.affiliation[Terzi, M.] 19 Mayis Univ, Samsun, Turkey.-
local.description.affiliation[Boz, C.] KTU, Med Fac, Farabi Hosp, Trabzon, Turkey.-
local.description.affiliation[Laureys, G.; Van Hijfte, L.] Univ Hosp Ghent, Ghent, Belgium.-
local.description.affiliation[Kermode, A.] Univ Western Australia, Nedlands, WA, Australia.-
local.description.affiliation[Garber, J.] Westmead Hosp, Sydney, NSW, Australia.-
local.description.affiliation[Yamout, B.; Khoury, S. J.] Amer Univ, Beirut Med Ctr, Beirut, Lebanon.-
local.description.affiliation[Butzkueven, H.] MSBase Fdn, Melbourne, Australia.-
local.uhasselt.internationalyes-
item.fullcitationZhu, C.; Kalincik, T.; Horakova, D.; Zhen, Z.; Buzzard, K.; Skibina, O.; Alroughani, R.; Izquierdo, G.; Eichau, S.; Kuhle, J.; Patti, F.; Grand'Maison, F.; Hodgkinson, S.; Grammond, P.; Lechner-Scott, J.; Butler, E.; Prat, A.; Girard, M.; Duquette, P.; Macdonell, R.; Weinstock-Guttman, B.; Ozakbas, S.; Slee, M.; Sa, M. Jose; Van Pesch, V.; Barnett, M.; VAN WIJMEERSCH, Bart; Gerlach, O.; Prevost, J.; Terzi, M.; Boz, C.; Laureys, G.; Van Hijfte, L.; Kermode, A.; Garber, J.; Yamout, B.; Khoury, S. J.; Jokubaitis, V.; Monif, M.; Merlo, D.; Van der Walt, A. & Butzkueven, H. (2022) Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation. In: Multiple Sclerosis Journal, 28 (S3) , p. 645 -647.-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
item.contributorZhu, C.-
item.contributorKalincik, T.-
item.contributorHorakova, D.-
item.contributorZhen, Z.-
item.contributorBuzzard, K.-
item.contributorSkibina, O.-
item.contributorAlroughani, R.-
item.contributorIzquierdo, G.-
item.contributorEichau, S.-
item.contributorKuhle, J.-
item.contributorPatti, F.-
item.contributorGrand'Maison, F.-
item.contributorHodgkinson, S.-
item.contributorGrammond, P.-
item.contributorLechner-Scott, J.-
item.contributorButler, E.-
item.contributorPrat, A.-
item.contributorGirard, M.-
item.contributorDuquette, P.-
item.contributorMacdonell, R.-
item.contributorWeinstock-Guttman, B.-
item.contributorOzakbas, S.-
item.contributorSlee, M.-
item.contributorSa, M. Jose-
item.contributorVan Pesch, V.-
item.contributorBarnett, M.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorGerlach, O.-
item.contributorPrevost, J.-
item.contributorTerzi, M.-
item.contributorBoz, C.-
item.contributorLaureys, G.-
item.contributorVan Hijfte, L.-
item.contributorKermode, A.-
item.contributorGarber, J.-
item.contributorYamout, B.-
item.contributorKhoury, S. J.-
item.contributorJokubaitis, V.-
item.contributorMonif, M.-
item.contributorMerlo, D.-
item.contributorVan der Walt, A.-
item.contributorButzkueven, H.-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Efficacy and persistence between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation.pdfPublished version7.12 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.